Company / Cost of Revenue
VYCOR MEDICAL INC Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$302.3K
FY2025
5-year range
$134.7K / $302.3K
FY2021-FY2025
Trend
+81.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cost of Revenue has increased for 5 consecutive years, from $132,463 in FY2020 to $302,293 in FY2025.
Based on SEC 10-K filings.
$302,293 in FY2025 with a 5-year CAGR of +17.9%.
Increased from $144,950 to $302,293 over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +29.1%
- 5-Year CAGR
- +17.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- VYCOR MEDICAL INC's cost of revenue has grown for 5 consecutive years.
- 5-year CAGR of +17.9%, indicating consistent growth.
- In FY2025, cost of revenue increased 81.2% year-over-year.
- Lowest cost of revenue in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -35.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $302.3K | +81.2% |
| FY2024 | $166.8K | +15.1% |
| FY2023 | $144.9K | +3.1% |
| FY2022 | $140.6K | +4.4% |
| FY2021 | $134.7K | +1.7% |
| FY2020 | $132.5K | -1.7% |
| FY2019 | $134.8K | -20.5% |
| FY2018 | $169.6K | -25.3% |
| FY2017 | $227.1K | +23.0% |
| FY2016 | $184.7K | +18.2% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026